JPH05500226A - 新規キサンチン化合物 - Google Patents
新規キサンチン化合物Info
- Publication number
- JPH05500226A JPH05500226A JP3501868A JP50186891A JPH05500226A JP H05500226 A JPH05500226 A JP H05500226A JP 3501868 A JP3501868 A JP 3501868A JP 50186891 A JP50186891 A JP 50186891A JP H05500226 A JPH05500226 A JP H05500226A
- Authority
- JP
- Japan
- Prior art keywords
- xanthine
- compound
- formula
- group
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (12)
- 1.一般式 ▲数式、化学式、表等があります▼I 但し式中R1は直鎖または分岐した炭素数3〜6のアルキル、アルケニルまたは アルキニル基であり、R2およびR3は同一または相異なることができてそれぞ れ水素またはハロゲンまたはメチル、メトキシ、ニトロまたはトリフルオロメチ ル基を表すか或いは一緒になってメチレンジオキシまたはエチレンジオキシ基を 表すが、R2およびR3は両方ともが水素ではないものとする、 を有することを特徴とする化合物、およびそのアルカリ金属塩基または含窒素有 機塩基との薬理的に許容される塩。
- 2.R1がn−プロピル、イソプロピル、n−ブチル、イソブチル、t−ブチル またはn−ヘキシル基である特許請求の範囲第1項記載の化合物。
- 3.R2およびR3は同一または相異なることができ、それぞれH、F、Cl、 Br、またはメトキシを表すか、またはR2およびR3は一緒になってメチレン ジオキシ基を表すことを特徴とする特許請求の範囲第1項記載の化合物。
- 4.該化合物が1−n−プロピル−3−(4−クロロフェニル)−キサンチン、 1−n−プロピル−3−(3,4−ジクロロフェニル)−キサンチン、1−n− ブチル−3−(3−ニトロフェニル)−キサンチン、1−n−ブチル−3−(3 −メトキシフェニル)−キサンチン、または1−n−ヘキシル−3−(3.4− メチレンジオキシフェニル)−キサンチンであることを特徴とする特許請求の範 囲第1項記載の化合物。
- 5.一般式 ▲数式、化学式、表等があります▼ 但し式中R1は直鎖または分岐した炭素数3〜6のアルキル、アルケニルまたは アルキニル基であり、R2およびR3は同一または相異なることができてそれぞ れ水素またはハロゲンまたはメチル、メトキシ、ニトロまたはトリフルオロメチ ル基を表すか或いは緒になってメチレンジオキソまたはエチレンジオキシ基を表 すが、R2およびR3は両方ともが水素ではないものとする、 を有する化合物、およびそのアルカリ金属塩基または含窒素有機塩基との薬理的 に許容される塩の製造法において、一般式▲数式、化学式、表等があります▼I V但し式中R1、R2およびR3は上記定義の通り、の5,6−ジアミンをフォ ルムアミドと反応させることを特徴とする方法。
- 6.該5,6−ジアミン化合物は一般式▲数式、化学式、表等があります▼II Iの6−アミノ−5−ニトロソ化合物を還元することにより製造されることを特 徴とする特許請求の範囲第5項記載の方法。
- 7.該6−アミノ−5−ニトロソ化合物は一般式▲数式、化学式、表等がありま す▼IIの6−アミノウラシルをニトロソ化して製造されることを特徴とする特 許請求の範囲第6項記載の方法。
- 8.該6−アミノ−5−ニトロソ化合物および5,6−ジアミ化合物はその場で つくられることを特徴とする特許請求の範囲第5〜7項記載の方法。
- 9.式IIの6−アミノキサンチンを過剰のフォルムアミド中で亜硝酸ナトリウ ムおよび蟻酸と反応させ、反応混合物に亜ニチオン酸ナトリウムを加えて得られ た6−アミノ−5−ニトロソ化合物を還元することを特徴とする特許請求の範囲 第8項記載の方法。
- 10.得られた式工のキサンチンをアルカリ金属塩基または含窒素有機塩基との 塩の形で分離することを特徴とする特許請求の範囲第5〜9項記載の方法。
- 11.特許請求の範囲第5項記載の一般式Iのキサンチンまたはその塩と薬理的 に許容される担体または希釈剤とから成ることを特徴とする薬物組成物。
- 12.人または動物の治療に使用することを特徴とする特許請求の範囲第1〜4 項記載のキサンチンまたはその塩。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8929208.0 | 1989-12-27 | ||
GB898929208A GB8929208D0 (en) | 1989-12-27 | 1989-12-27 | New xanthine derivatives |
PCT/GB1990/002027 WO1991009859A1 (en) | 1989-12-27 | 1990-12-27 | New xanthine derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05500226A true JPH05500226A (ja) | 1993-01-21 |
JPH089617B2 JPH089617B2 (ja) | 1996-01-31 |
Family
ID=10668520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3501868A Expired - Fee Related JPH089617B2 (ja) | 1989-12-27 | 1990-12-27 | 新規キサンチン化合物 |
Country Status (30)
Country | Link |
---|---|
US (1) | US5223504A (ja) |
EP (1) | EP0435811B1 (ja) |
JP (1) | JPH089617B2 (ja) |
KR (1) | KR970001528B1 (ja) |
CN (1) | CN1029967C (ja) |
AT (1) | ATE93860T1 (ja) |
AU (1) | AU635104B2 (ja) |
BR (1) | BR9007258A (ja) |
CA (1) | CA2045478C (ja) |
CZ (1) | CZ278328B6 (ja) |
DE (1) | DE69003087T2 (ja) |
DK (1) | DK0435811T3 (ja) |
EG (1) | EG19436A (ja) |
ES (1) | ES2058864T3 (ja) |
FI (1) | FI96207C (ja) |
GB (1) | GB8929208D0 (ja) |
HU (2) | HU208825B (ja) |
IE (1) | IE64065B1 (ja) |
IL (1) | IL96708A (ja) |
MX (1) | MX23884A (ja) |
MY (1) | MY105303A (ja) |
NO (1) | NO178111C (ja) |
NZ (1) | NZ236517A (ja) |
PL (1) | PL166152B1 (ja) |
PT (1) | PT96332B (ja) |
RU (1) | RU2073679C1 (ja) |
SK (1) | SK278365B6 (ja) |
UA (1) | UA32512C2 (ja) |
WO (1) | WO1991009859A1 (ja) |
ZA (1) | ZA9010240B (ja) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521315A (en) * | 1993-01-12 | 1996-05-28 | Cell Therapeutics, Inc. | Olefin substituted long chain compounds |
GB9312853D0 (en) | 1993-06-22 | 1993-08-04 | Euro Celtique Sa | Chemical compounds |
US5591776A (en) | 1994-06-24 | 1997-01-07 | Euro-Celtique, S.A. | Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
US5922751A (en) | 1994-06-24 | 1999-07-13 | Euro-Celtique, S.A. | Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same |
US5661153A (en) * | 1994-07-19 | 1997-08-26 | Japan Energy Corporation | 1-arylpyrimidine derivatives and pharmaceutical use thereof |
US6025361A (en) * | 1994-12-13 | 2000-02-15 | Euro-Celtique, S.A. | Trisubstituted thioxanthines |
ATE247655T1 (de) | 1994-12-13 | 2003-09-15 | Euro Celtique Sa | Dreifachsubstituierte thioxanthine |
EP0814809B1 (en) | 1994-12-13 | 2003-08-13 | Euroceltique S.A. | Aryl thioxanthines |
WO1996036638A1 (en) * | 1995-05-19 | 1996-11-21 | Chiroscience Limited | Xanthines and their therapeutic use |
US6166041A (en) | 1995-10-11 | 2000-12-26 | Euro-Celtique, S.A. | 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma |
US6075016A (en) | 1996-04-10 | 2000-06-13 | Euro-Celtique S.A. | 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity |
US5864037A (en) | 1996-06-06 | 1999-01-26 | Euro-Celtique, S.A. | Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity |
US5958926A (en) | 1996-11-01 | 1999-09-28 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
US6331543B1 (en) * | 1996-11-01 | 2001-12-18 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
US5874437A (en) * | 1996-11-01 | 1999-02-23 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
CA2270118A1 (en) * | 1996-11-01 | 1998-05-14 | Nitromed Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
USRE37234E1 (en) * | 1996-11-01 | 2001-06-19 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses |
GB9623859D0 (en) * | 1996-11-15 | 1997-01-08 | Chiroscience Ltd | Novel compounds |
US6472425B1 (en) | 1997-10-31 | 2002-10-29 | Nitromed, Inc. | Methods for treating female sexual dysfunctions |
IL132407A0 (en) * | 1998-10-21 | 2001-03-19 | Pfizer Prod Inc | Method for treating congestive heart failure |
DE60014353T2 (de) * | 1999-05-04 | 2005-10-13 | Altana Pharma Ag | Synergistische kombination von roflumilast und pde-3 hemmern |
SK287231B6 (sk) | 1999-08-21 | 2010-04-07 | Nycomed Gmbh | Liečivo zahŕňajúce PDE inhibítor a agonistu beta2 adrenoreceptora |
GB0005199D0 (en) * | 2000-03-04 | 2000-04-26 | Imp College Innovations Ltd | Modulation of histone deacetylase |
EP1265861A2 (en) | 2000-03-16 | 2002-12-18 | Inflazyme Pharmaceuticals, Ltd. | Benzylated pde4 inhibitors |
JP4510383B2 (ja) * | 2001-05-23 | 2010-07-21 | 田辺三菱製薬株式会社 | 軟骨疾患修復治療用組成物 |
WO2002094321A1 (fr) * | 2001-05-23 | 2002-11-28 | Tanabe Seiyaku Co., Ltd. | Compositions favorisant la guérison d'une fracture osseuse |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
MXPA05010373A (es) | 2003-04-01 | 2005-12-05 | Applied Research Systems | Inhibidores de fosfodiesterasas en infertilidad. |
EP2170930B3 (en) | 2007-06-04 | 2013-10-02 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
EP2328910B1 (en) | 2008-06-04 | 2014-08-06 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
AU2009270833B2 (en) | 2008-07-16 | 2015-02-19 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
KR102034748B1 (ko) | 2011-03-01 | 2019-10-21 | 시너지 파마슈티컬즈 인코포레이티드 | 구아닐레이트 사이클라제 c 작용제의 제조 방법 |
CA2902348C (en) | 2013-02-25 | 2021-11-30 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
JP2016514670A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト |
AU2014235215A1 (en) | 2013-03-15 | 2015-10-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
BR112015030326A2 (pt) | 2013-06-05 | 2017-08-29 | Synergy Pharmaceuticals Inc | Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos |
EP3884935B1 (en) | 2013-08-09 | 2023-06-14 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
EP3165224A1 (en) | 2015-11-09 | 2017-05-10 | Albert-Ludwigs-Universität Freiburg | Use of pde4 inhibitors for the prophylaxis and/or therapy of dyslipoproteinaemia and related disorders |
WO2017089347A1 (en) | 2015-11-25 | 2017-06-01 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods and pharmaceutical compositions for the treatment of braf inhibitor resistant melanomas |
AR115689A1 (es) | 2018-07-05 | 2021-02-17 | Sumitomo Chemical Co | Compuestos de uracilo y su utilización |
US20200368223A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Methods for inhibiting phosphate transport |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1245969B (de) * | 1967-08-03 | VEB Arzneimittelwerk Dresden, Radebeul | Verfahren zur Herstellung von Xanthinderivaten | |
CH629788A5 (de) * | 1977-07-20 | 1982-05-14 | Lonza Ag | Verfahren zur herstellung von 5,6-diaminouracil. |
SE416810C (sv) * | 1977-10-14 | 1982-07-19 | Draco Ab | Forfarande for framstellning av xantinderivat med antiallergisk aktivitet |
GB8826595D0 (en) * | 1988-11-14 | 1988-12-21 | Beecham Wuelfing Gmbh & Co Kg | Active compounds |
-
1989
- 1989-12-27 GB GB898929208A patent/GB8929208D0/en active Pending
-
1990
- 1990-12-18 CZ CS906341A patent/CZ278328B6/cs not_active IP Right Cessation
- 1990-12-18 NZ NZ236517A patent/NZ236517A/xx unknown
- 1990-12-18 IL IL9670890A patent/IL96708A/en not_active IP Right Cessation
- 1990-12-18 SK SK6341-90A patent/SK278365B6/sk unknown
- 1990-12-19 ZA ZA9010240A patent/ZA9010240B/xx unknown
- 1990-12-19 DK DK90500126.9T patent/DK0435811T3/da active
- 1990-12-19 DE DE90500126T patent/DE69003087T2/de not_active Expired - Fee Related
- 1990-12-19 ES ES90500126T patent/ES2058864T3/es not_active Expired - Lifetime
- 1990-12-19 AT AT90500126T patent/ATE93860T1/de not_active IP Right Cessation
- 1990-12-19 EP EP90500126A patent/EP0435811B1/en not_active Expired - Lifetime
- 1990-12-20 EG EG75090A patent/EG19436A/xx active
- 1990-12-20 IE IE463490A patent/IE64065B1/en not_active IP Right Cessation
- 1990-12-21 CN CN90110056A patent/CN1029967C/zh not_active Expired - Fee Related
- 1990-12-21 PT PT96332A patent/PT96332B/pt not_active IP Right Cessation
- 1990-12-21 MX MX2388490A patent/MX23884A/es unknown
- 1990-12-21 MY MYPI90002243A patent/MY105303A/en unknown
- 1990-12-27 UA UA5001584A patent/UA32512C2/uk unknown
- 1990-12-27 BR BR909007258A patent/BR9007258A/pt not_active Application Discontinuation
- 1990-12-27 HU HU912782A patent/HU208825B/hu not_active IP Right Cessation
- 1990-12-27 RU SU905001584A patent/RU2073679C1/ru not_active IP Right Cessation
- 1990-12-27 US US07/743,388 patent/US5223504A/en not_active Expired - Lifetime
- 1990-12-27 KR KR1019910700878A patent/KR970001528B1/ko not_active IP Right Cessation
- 1990-12-27 AU AU69768/91A patent/AU635104B2/en not_active Ceased
- 1990-12-27 WO PCT/GB1990/002027 patent/WO1991009859A1/en active IP Right Grant
- 1990-12-27 CA CA002045478A patent/CA2045478C/en not_active Expired - Fee Related
- 1990-12-27 PL PL90292006A patent/PL166152B1/pl not_active IP Right Cessation
- 1990-12-27 JP JP3501868A patent/JPH089617B2/ja not_active Expired - Fee Related
-
1991
- 1991-08-19 NO NO913236A patent/NO178111C/no unknown
- 1991-08-26 FI FI914014A patent/FI96207C/fi active
-
1995
- 1995-06-30 HU HU95P/P00698P patent/HU211573A9/hu unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH05500226A (ja) | 新規キサンチン化合物 | |
EP0011609B1 (en) | Xanthine derivatives and pharmaceutical preparations containing these derivatives for use in the treatment of chronic obstructive airway disease and cardiac disease | |
JPH0130834B2 (ja) | ||
JPH0641466B2 (ja) | ピラゾロトリアジン誘導体およびそれを含有するキサンチンオキシダーゼ阻害剤 | |
JPH0825879B2 (ja) | 抗うつまたは抗パーキンソン病薬 | |
HU190683B (en) | Process for preparing substituted 3-amino-sydnone imines | |
EP0038784B1 (en) | 3,8-dialkylxanthines, processes for their preparation and compositions containing them | |
JPS6322082A (ja) | 1―(ヒドロキシスチリル)―5h―2,3―ベンゾジアゼピン誘導体およびその製造方法、並びに前記誘導体を含む薬剤 | |
CN109369623B (zh) | 一种取代1,2,3三氮唑类二芳基嘧啶衍生物及其制备方法与应用 | |
JPS6344577A (ja) | ピリミジン誘導体 | |
CZ174397A3 (en) | Use of xanthine derivatives for preparing a medicament for treating and prophylaxis of shock diseases, novel xanthine derivatives and process of their preparation | |
CA2122290A1 (fr) | Composes pyrrolopyraziniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
CN110627795A (zh) | 磷酸二酯酶抑制剂及其用途 | |
US4423073A (en) | Fluorinated diaminopentene derivatives | |
JPH11512734A (ja) | Pnpインヒビターとしてのプリンとグアニンの誘導体 | |
JPH11512735A (ja) | プリンとグアニンの誘導体 | |
HU220760B1 (hu) | A-2-receptor affinitású R-2-[(fenil-izopropil)-amino]-adenozin, előállítása, alkalmazása és azt tartalmazó gyógyszerkészítmény | |
JP2001523213A (ja) | 三置換チオキサンチン類 | |
JPH0564631B2 (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080131 Year of fee payment: 12 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090131 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090131 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100131 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100131 Year of fee payment: 14 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100131 Year of fee payment: 14 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
LAPS | Cancellation because of no payment of annual fees |